MarketCapTrends
ABUS
Arbutus Biopharma Corporation (ABUS)
NASDAQ · Healthcare

Arbutus Biopharma Corporation Cash on Hand 2011–2025

Arbutus Biopharma Corporation annual/quarterly cash on hand history from 2013 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.

  • Arbutus Biopharma Corporation cash on hand for the quarter ending December 31, 2025 were 18.0M, a 50.43% decrease year-over-year.
  • Arbutus Biopharma Corporation cash on hand for 2025 were 18.0M, a 50.43% decrease from 2024.
  • Arbutus Biopharma Corporation cash on hand for 2024 were 36.3M, a 38.22% increase from 2023.
  • Arbutus Biopharma Corporation cash on hand for 2023 were 26.3M, a 14.59% decrease from 2022.
  • Arbutus Biopharma Corporation cash on hand for 2022 were 30.8M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Arbutus Biopharma Corporation Annual Cash on Hand (Millions of US $)
2025$18
2024$36
2023$26
2022$31
2021$109
2020$52
2019$32
2018$37
2017$54
2016$23
2015$167
2014$72
2013$69
Arbutus Biopharma Corporation Quarterly Cash on Hand (Millions of US $)
2025-12-31$18
2024-12-31$36
2023-12-31$26
2022-12-31$31
2021-12-31$109
2020-12-31$52
2019-12-31$32
2018-12-31$37
2017-12-31$54
2016-12-31$23
2015-12-31$167
2014-12-31$72
2013-12-31$69

Arbutus Biopharma Corporation Cash on Hand — FAQ

Arbutus Biopharma Corporation (ABUS) cash on hand over the last 15 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ABUS's cash on hand history?

The chart and table above show Arbutus Biopharma Corporation's cash on hand by year and by quarter, including the growth rate.